HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer.

Abstract
The collagen IV binding receptor integrin alpha1beta1 has been shown to regulate lung cancer due to its proangiogenic properties; however, it is unclear whether this receptor also plays a direct role in promoting primary lung tumors. To investigate this possibility, integrin alpha1-null mice were crossed with KrasLA2 mice that carry an oncogenic mutation of the Kras gene (G12D) and develop spontaneous primary tumors with features of non-small cell lung cancer. We provide evidence that KrasLA2/alpha1-null mice have a decreased incidence of primary lung tumors and longer survival compared with KrasLA2/alpha1 wild-type controls. Tumors from KrasLA2/alpha1-null mice were also smaller, less vascularized, and exhibited reduced cell proliferation and increased apoptosis, as determined by proliferating cell nuclear antigen and terminal deoxynucleotidyl-transferase-mediated dUTP nick-end staining, respectively. Moreover, tumors from the KrasLA2/alpha1-null mice showed diminished extracellular signal-regulated kinase (ERK) but enhanced p38 mitogen-activated protein kinase activation. Primary lung tumor epithelial cells isolated from KrasLA2/alpha1-null mice showed a significant decrease in anchorage-independent colony formation, collagen-mediated cell proliferation, ERK activation, and, most importantly, tumorigenicity when injected into nude mice compared with KrasLA2/alpha1 wild-type tumor cells. These results indicate that loss of the integrin alpha1 subunit decreases the incidence and growth of lung epithelial tumors initiated by oncogenic Kras, suggesting that both Kras and integrin alpha1beta1 cooperate to drive the growth of non-small cell lung cancer in vivo.
AuthorsInes Macias-Perez, Corina Borza, Xiwu Chen, Xuexian Yan, Raquel Ibanez, Glenda Mernaugh, Lynn M Matrisian, Roy Zent, Ambra Pozzi
JournalCancer research (Cancer Res) Vol. 68 Issue 15 Pg. 6127-35 (Aug 01 2008) ISSN: 1538-7445 [Electronic] United States
PMID18676835 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Collagen Type IV
  • Integrin alpha1beta1
  • Extracellular Signal-Regulated MAP Kinases
Topics
  • Animals
  • Cell Adhesion
  • Cell Proliferation
  • Collagen Type IV (metabolism)
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Genes, ras
  • Immunohistochemistry
  • Integrin alpha1beta1 (genetics, physiology)
  • Lung Neoplasms (blood supply, enzymology, genetics, pathology)
  • Mice
  • Mice, Knockout
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: